EP2640377
FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.11.2011EP published:
26.12.2018EP application number:
11784918.2
EPO information:
European Patent Register
Max expiry date:
13.11.2031
Title:
FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES
Timeline
Today
14.11.2011EP application
26.12.2018EP Publication
Owner
Name:
Five Prime Therapeutics, Inc.Address:
111 Oyster Point Boulevard, 94080, South San Francisco, CA, US
Inventor
Name:
LONG, LiAddress:
Lafayette, California, US
Name:
BRENNAN, ThomasAddress:
San Jose, California, US
Priority
Number:
413940 PDate:
15.11.2010Country:
US
Number:
421462 PDate:
9.12.2010Country:
US
Classification
Categories:
A61K 31/337, A61K 31/475, A61K 31/519, A61K 38/18, A61K 45/06, A61P 35/00, A61K 39/395, A61K 31/4745, A61K 31/513, A61K 31/555, A61K 31/704, A61K 31/7048, A61K 33/24, A61K 38/17, C07K 19/00, C07K 14/71